XClose

UCL News

Home
Menu

How widely will the new weight loss drug, semaglutide, be prescribed?

8 March 2023

Dr Alexander van Tulleken (UCL Institute for Global Health) explains the potential benefits and limitations of the new weight loss drug, semaglutide, approved for NHS use to tackle obesity.

Listen: BBC Radio 4 'Today' (from 2 hours, 50 mins, 31 secs)